Entera Bio (ENTX) Institutional Ownership $2.34 +0.11 (+4.93%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Entera Bio (NASDAQ:ENTX)CurrentInstitutional OwnershipPercentage14.11%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$144.89KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$31.83K Get ENTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Entera Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ENTX Institutional Buying and Selling by Quarter Entera Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024Parkman Healthcare Partners LLC411,076$781K0.1%+2.4%1.149% 11/6/2024Signature Estate & Investment Advisors LLC47,328$90K0.0%N/A0.132% 8/9/2024Renaissance Technologies LLC57,600$106K0.0%-23.1%0.161% 5/20/2024Virtu Financial LLC22,040$37K0.0%N/A0.000% 2/14/2023RA Capital Management L.P.295,966$216K0.0%-85.8%1.028% 11/14/2022RA Capital Management L.P.2,082,372$2.17M0.0%-11.5%7.229% 1/31/2022Altium Wealth Management LLC11,830$33K0.0%N/A0.050% 1/28/2022ARK Investment Management LLC690,922$1.95M0.0%+1.2%2.915% 8/17/2021Knoll Capital Management LLC2,484,275$14.86M7.8%+38.7%10.482% 8/16/2021RA Capital Management L.P.2,353,000$14.07M0.2%N/A9.928% 8/13/2021Geode Capital Management LLC17,597$105K0.0%N/A0.074% 8/11/2021Susquehanna Fundamental Investments LLC14,400$86K0.0%N/A0.061% 6/14/2021Knoll Capital Management LLC1,791,363$6.83M4.4%+2.9%7.558% 5/18/2021Millennium Management LLC38,611$147K0.0%N/A0.163% 5/14/2021XTX Topco Ltd11,559$44K0.0%N/A0.101% 5/13/2021Renaissance Technologies LLC120,407$459K0.0%+66.8%1.053% 2/24/2021Virtu Financial LLC31,314$34K0.0%N/A0.274% 2/10/2021Renaissance Technologies LLC72,186$78K0.0%N/A0.632% (Data available from 1/1/2016 forward) ENTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ENTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Entera Bio shares: Parkman Healthcare Partners LLC ($781K), RA Capital Management L.P. ($216K), Renaissance Technologies LLC ($106K), and Signature Estate & Investment Advisors LLC ($90K), Virtu Financial LLC ($37K).Learn more on ENTX's institutional investors. What percentage of Entera Bio stock is owned by institutional investors? 14.11% of Entera Bio stock is owned by institutional investors. Learn more on ENTX's institutional investor holdings. Which institutional investors have been buying Entera Bio stock? The following institutional investors have purchased Entera Bio stock in the last 24 months: Signature Estate & Investment Advisors LLC ($47.33K), Virtu Financial LLC ($22.04K), and Parkman Healthcare Partners LLC ($9.56K). How much institutional buying is happening at Entera Bio? Institutional investors have bought a total of 78,926 shares in the last 24 months. This purchase volume represents approximately $144.89K in transactions. Which Entera Bio major shareholders have been selling company stock? The following institutional investors have sold Entera Bio stock in the last 24 months: RA Capital Management L.P. ($1.79M), and Renaissance Technologies LLC ($17.30K). How much institutional selling is happening at Entera Bio? Institutional investors have sold a total of 1,803,706 shares in the last 24 months. This volume of shares sold represents approximately $1.34M in transactions. Related Companies Korro Bio Institutional Ownership Revance Therapeutics Institutional Ownership Contineum Therapeutics Institutional Ownership Monte Rosa Therapeutics Institutional Ownership REGENXBIO Institutional Ownership Alumis Institutional Ownership Taysha Gene Therapies Institutional Ownership Corvus Pharmaceuticals Institutional Ownership Precigen Institutional Ownership Tango Therapeutics Institutional Ownership This page (NASDAQ:ENTX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENTX Stock Alerts